机构:[1]Department of Neurology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, China.[2]Department of Neurology, Xuanwu Hospital, National Center for Neurological Disorders, Capital Medical University, Beijing 100053, China.神经科系统神经内科首都医科大学宣武医院[3]Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin 150081, Heilongjiang, China.[4]Department of Radiology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, China.[5]Department of Cardiology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, China.
To better differentiate neuromyelitis optica spectrum disorder (NMOSD) from myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), it is crucial to systematically explore the correlation between their clinical and immunological characteristics. Utilizing high-throughput protein detection technologies, we analyzed 92 inflammation-related proteins in plasma samples from NMOSD (n = 50), NMOSD-like MOGAD (n = 12), and encephalitis-like MOGAD (n = 8) groups. In this study, we found that seizures (2% vs 30%, p < 0.001) and acute disseminated encephalomyelitis (0% vs 30%, p < 0.001) were more common in MOGAD, while transverse myelitis (52% vs 5%, p < 0.001) was more common in NMOSD. The signs and symptoms of NMOSD-like and encephalitis-like MOGAD were largely similar. There were no significant differentially expressed proteins identified between the NMOSD group and the NMOSD-like MOGAD group, while the elevated IL-24 and TRANCE were in the encephalitis-like MOGAD group rather than in the NMOSD group. There was a positive correlation of CCL20 expression with EDSS scores in the NMOSD group, while this association was not found in the other groups. In conclusion, encephalitis-like MOGAD has distinct clinical and peripheral inflammatory protein characteristics compared to NMOSD and NMOSD-like MOGAD. Some differential IRPs are closely associated with specific clinical parameters.
基金:
the Beijing Research Ward
Excellence Program (BRWEP2024W022010104), the Beijing
Municipal Public Welfare Development and Reform Pilot
Project for Medical Research Institutes, the National Natural
Science Foundation of China (Grant No. 82101416), and the
Natural Science Foundation of Liaoning Province (2023JH2/20200149).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|2 区生物学
小类|2 区生化研究方法
最新[2025]版:
大类|2 区生物学
小类|2 区生化研究方法
第一作者:
第一作者机构:[1]Department of Neurology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, China.[2]Department of Neurology, Xuanwu Hospital, National Center for Neurological Disorders, Capital Medical University, Beijing 100053, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Neurology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, China.[2]Department of Neurology, Xuanwu Hospital, National Center for Neurological Disorders, Capital Medical University, Beijing 100053, China.
推荐引用方式(GB/T 7714):
Wei Quanfeng,Meng Su,Zhao Chenyang,et al.Distinct Inflammatory Profiles and Clinical Characteristics of NMOSD: A Comparative Analysis with NMOSD-like and Encephalitis-like MOG-AD[J].Journal Of Proteome Research.2025,doi:10.1021/acs.jproteome.5c00448.
APA:
Wei Quanfeng,Meng Su,Zhao Chenyang,Wang Minghe,Yang Shanshan...&Hu Wenyu.(2025).Distinct Inflammatory Profiles and Clinical Characteristics of NMOSD: A Comparative Analysis with NMOSD-like and Encephalitis-like MOG-AD.Journal Of Proteome Research,,
MLA:
Wei Quanfeng,et al."Distinct Inflammatory Profiles and Clinical Characteristics of NMOSD: A Comparative Analysis with NMOSD-like and Encephalitis-like MOG-AD".Journal Of Proteome Research .(2025)